Radioactive 'Tumor Seeker' drug enters first human trials for tough cancers
Disease control
Recruiting now
This is a first-in-human study testing a new experimental drug called 212Pb-DOTAM-GRPR1 in adults with advanced cancers that have returned or spread. The main goal is to find a safe and tolerable dose. Researchers will also check if the drug, which delivers radiation directly to …
Phase: PHASE1 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC